The Essential Frailty Toolset in Older Adults Undergoing Aortic Valve Replacement
Read more about the project here.
FRAILTY-AVR was a Canadian-led study in which >1,000 older adults undergoing transcatheter and surgical aortic valve replacement were enrolled prospectively to determine the impact of frailty on mortality, morbidity, and patient-centered outcomes.
This study generated a wealth of data on frailty and ancillary geriatric domains, which are being integrated in the pre-procedural evaluation of older cardiovascular patients. Moreover, this study was instrumental in developing a parsimonious frailty scale known as the Essential Frailty Toolset (EFT).
With the support of a knowledge translation grant from CFN, our team has created and launched the www.FrailtyTool.com smartphone app to facilitate the task of using the EFT in day-to-day clinical practice in order to individualize care for vulnerable patients.
Jonathan Afilalo, MD, MSc, FACC, FRCPC is an Associate Professor in the Department of Medicine at McGill University, and a Cardiologist in the Azrieli Heart Centre and Centre for Clinical Epidemiology at the Jewish General Hospital. Dr. Afilalo completed his MD and MSc Epidemiology at McGill University and his fellowship training at Harvard University. His research interests relate to frailty and risk prediction in older adults with cardiovascular disease, and include projects examining the impact of frailty assessment tools and novel biomarkers for frailty, and the treatment of frailty to improve outcomes after cardiac procedures.